REPROCELL Webinars
![WEBINAR Innovative Technology to Bioengineer human tissue](https://www.reprocell.com/hs-fs/hubfs/WEBINAR%20Innovative%20Technology%20to%20Bioengineer%20human%20tissue.webp?width=1280&height=720&name=WEBINAR%20Innovative%20Technology%20to%20Bioengineer%20human%20tissue.webp)
Innovative Technology to Bioengineer human tissue
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
![Mature chamber specific human cardiomyocytes video cover](https://www.reprocell.com/hs-fs/hubfs/Mature%20chamber%20specific%20human%20cardiomyocytes%20video%20cover.png?width=1280&height=720&name=Mature%20chamber%20specific%20human%20cardiomyocytes%20video%20cover.png)
Mature Chamber Specific Human Cardiomyocytes for High Throughput Cardiotoxicity Testing
Anne E. Sheldrake, M.S.
(StemBioSys)
Todd J. Herron, Ph.D.
(Frankel Cardiovascular Center, University of Michigan)
![](https://www.reprocell.com/hs-fs/hubfs/MSC-yt-thumbnail.jpg?width=1280&height=720&name=MSC-yt-thumbnail.jpg)
Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects
Evelyn Chukwurah, Ph.D.
(REPROCELL USA)
Naiarah de Paz, M.Sc.
(COO, Histocell)
![](https://www.reprocell.com/hs-fs/hubfs/Customized%20Central%20Laboratory%20Services%20for%20Support%20of%20Global%20Clinical%20Trials%20PBMC%20Processing.webp?width=1280&height=720&name=Customized%20Central%20Laboratory%20Services%20for%20Support%20of%20Global%20Clinical%20Trials%20PBMC%20Processing.webp)
Customized Central Laboratory Services for Support of Global Clinical Trials: PBMC Processing
Dr Nikola Kolundzic
Study Director, REPROCELL Europe, UK
![](https://www.reprocell.com/hs-fs/hubfs/Working%20with%20Mature%20Chamber-Specific%20Cardiomyocytes.webp?width=1280&height=720&name=Working%20with%20Mature%20Chamber-Specific%20Cardiomyocytes.webp)
Working with Mature, Chamber-Specific Cardiomyocytes
Dr Travis Block
Chief Technology Officer, StemBioSys
![](https://www.reprocell.com/hs-fs/hubfs/Human%20Tissue%20in%20Drug%20Discovery%20Scientific%20Technical%20%26%20Regulatory%20Perspective.webp?width=1280&height=720&name=Human%20Tissue%20in%20Drug%20Discovery%20Scientific%20Technical%20%26%20Regulatory%20Perspective.webp)
Human Tissue in Drug Discovery Scientific, Technical & Regulatory Perspective
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
![](https://www.reprocell.com/hs-fs/hubfs/Clinically%20compatible%20advances%20in%20blood-derived%20EPC%20isolation%20and%20reprogramming.jpg?width=1280&height=720&name=Clinically%20compatible%20advances%20in%20blood-derived%20EPC%20isolation%20and%20reprogramming.jpg)
Clinically compatible advances in blood-derived EPC isolation and reprogramming
Dr Amer Rana
Director of Biomedical Research Center, University of East Anglia, UK
![](https://www.reprocell.com/hs-fs/hubfs/Enabling%20translational%20research%20through%20access%20to%20high%20quality%20biospecimens.webp?width=1280&height=720&name=Enabling%20translational%20research%20through%20access%20to%20high%20quality%20biospecimens.webp)
Enabling translational research through access to high quality biospecimens
Dr. Rachna Goyal
Manager, Preclinical Genomics, REPROCELL USA
![](https://www.reprocell.com/hs-fs/hubfs/How%20to%20culture%20iPSCs%20in%20suspension%20without%20agitation.webp?width=1280&height=720&name=How%20to%20culture%20iPSCs%20in%20suspension%20without%20agitation.webp)
How to culture iPSCs in suspension without agitation
Masashi Iwakami
Nissan Chemical Corporation, Japan
![](https://www.reprocell.com/hs-fs/hubfs/Improving%20precision%20medicine%20with%20human%20tissue%20testing%20and%20genomics.webp?width=1280&height=720&name=Improving%20precision%20medicine%20with%20human%20tissue%20testing%20and%20genomics.webp)
Improving precision medicine with human tissue testing and genomics
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
![](https://www.reprocell.com/hs-fs/hubfs/Bioengineered%20Human%20Tissues%20for%20Skin%20Cancer%20and%20Drug%20Metabolism.webp?width=1280&height=720&name=Bioengineered%20Human%20Tissues%20for%20Skin%20Cancer%20and%20Drug%20Metabolism.webp)
Bioengineered Human Tissues for Skin, Cancer, and Drug Metabolism
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA
![](https://www.reprocell.com/hs-fs/hubfs/Providing%20testing%20solutions%20for%20the%20development%20of%20SARS-CoV-2%20therapeutics.webp?width=1280&height=720&name=Providing%20testing%20solutions%20for%20the%20development%20of%20SARS-CoV-2%20therapeutics.webp)
Providing testing solutions for the development of SARS-CoV-2 therapeutics
Prof. Anne Dickinson
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA
![](https://www.reprocell.com/hs-fs/hubfs/How%20Pharma%20is%20Using%20Human%20Tissues%20to%20Better%20Predict%20Drug%20Behaviour.webp?width=1280&height=720&name=How%20Pharma%20is%20Using%20Human%20Tissues%20to%20Better%20Predict%20Drug%20Behaviour.webp)
How Pharma is using fresh human tissues to better predict drug safety and efficacy
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
![](https://www.reprocell.com/hs-fs/hubfs/Efficient%20iPSC%20culture%20using%20a%20novel%20animal-free%20culture%20system.webp?width=1280&height=720&name=Efficient%20iPSC%20culture%20using%20a%20novel%20animal-free%20culture%20system.webp)
Consistent and efficient hPSC culture with a novel animal-origin free culture system
Dr. Hajime Onuki
Ajinomoto Co. Inc.
![](https://www.reprocell.com/hs-fs/hubfs/Providing%20Safety%20Testing%20Solutions%20for%20the%20Pharmaceutical%20%26%20Cosmetic%20Industry.webp?width=1280&height=720&name=Providing%20Safety%20Testing%20Solutions%20for%20the%20Pharmaceutical%20%26%20Cosmetic%20Industry.webp)
Providing safety testing solutions for the pharmaceutical and cosmetic industry
Dr. Shaheda Ahmed
Scientific Manager, Alcyomics Ltd. UK
![](https://www.reprocell.com/hs-fs/hubfs/Novel%20Uses%20for%20PCR%20of%20iPSCs%20in%20Drug%20Discovery%20and%20Cell%20Biology.webp?width=1280&height=720&name=Novel%20Uses%20for%20PCR%20of%20iPSCs%20in%20Drug%20Discovery%20and%20Cell%20Biology.webp)
Novel Uses for PCR of iPSCs in Drug Discovery and Cell Biology
Dr. Tsukasa Sugo
CEO and Founder of GenAhead Bio in Fujisawa, Japan
![](https://www.reprocell.com/hs-fs/hubfs/The%20REPROCELL%20Biobank%20A%20Unique%20Tool%20for%20Neurodegenerative%20Disease%20Research.webp?width=1280&height=720&name=The%20REPROCELL%20Biobank%20A%20Unique%20Tool%20for%20Neurodegenerative%20Disease%20Research.webp)
The REPROCELL Biobank: A Unique Tool for Neurodegenerative Disease Research
Dr. Jean Phillipe Richard
Stem Cell Director, REPROCELL USA
![](https://www.reprocell.com/hs-fs/hubfs/Facilitating%20Dermatology%20Drug%20Development.webp?width=1280&height=720&name=Facilitating%20Dermatology%20Drug%20Development.webp)
The REPROCELL Tissue Network: Facilitating Dermatological Drug Development
Dr. Karen McAuley
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe
Animated Explainer Videos
Human Tissue Testing Videos
Note: Biopta (Glasgow, UK and Maryland, USA) is now REPROCELL’s Center for predictive Drug Discovery.
Alvetex Videos
Note: Reinnervate (Durham, UK) is now part of REPROCELL’s Center for predictive Drug Discovery.